Based on volume-flow relationships, CNS agents that are highly lipid soluble (log octanol-water partition coefficient 92) are expected to have equilibration half-times (T 1/2 k E0 ) that are proportional to brain solubility. Propofol, the most lipophilic anaesthetic in clinical use, has T 1/2 k E0 values of 1.7 and 2.9 min in rats and humans, respectively, compared with an expected value of at least 8 min. As a first step in exploring this discrepancy between observed and predicted values, we determined the steady state brain:plasma and brain:blood partition coefficients in rats after a 4-h infusion of propofol. Brain:plasma and brain:blood partition coefficients were 8.2 (SD 1.6) and 3.0 (0.5), respectively. T 1/2 k E0 predictions based on brain: blood partitioning in rats are more in agreement with the observed equilibration half-time, suggesting that drug bound to the formed elements of blood participates in the uptake and transfer of propofol to its effect site. (Br. J. Anaesth. 1998; 81: 422-424).
Propofol (2,6-diisopropyl phenol), a highly lipophilic (log octanol-water partition coefficient (Kp Octanol-Water ) 4.33) anaesthetic, exhibits a plasma effect-site equilibration half-time (T 1/2 k E0 ) of 1.7 and 2.9 min in rats 1 and humans, 2 respectively. Based on volume-flow relationships, the equilibration half-time of propofol in brain and apparent effect site would be expected to be proportional to its brain solubility. Paradoxically, the high lipophilicity of propofol suggests a high brain:plasma partition coefficient which should result in an expected T 1/2 k E0 of greater than 8 min in rats. As a first step in exploring this discrepancy, we determined the steady state brain:plasma (Kp Brain:Plasma ) and brain:blood (Kp Brain:Blood ) partition coefficients in rats. This is the first report of measurement of steady state brain:plasma and brain:blood distribution of propofol in the rat.
Materials and methods
Male Wistar rats chronically instrumented with venous (jugular) and arterial (femoral) catheters were given an infusion of Diprivan (Zeneca Pharmaceuticals) 0.5-0.8 mg h
91 for 4 h to achieve target arterial plasma concentrations of 1-2 g ml
91
.
This infusion rate produces and maintains a state of light anaesthesia in rats. Arterial blood (0.4 ml) was sampled at 0.5, 1, 2, 3, 3.5 and 4 h. The anaesthetized animals were sacrificed at 4 h by decapitation and the brain was harvested. Body weight and rectal temperature were monitored throughout the study.
Initially only the brain and plasma concentrations of propofol were measured in six animals (study 1). Kp Brain:Plasma determined from these animals was unexpectedly high. This high Kp Brain:Plasma value suggested a T 1/2 k E0 value of greater than 8 min compared with an observed value of 1.7 min in rats. Therefore, we performed a second study using six additional rats and the same procedure as in study 1. In the second study, we measured plasma and whole blood, in addition to brain concentrations of propofol.
Propofol concentrations in rat plasma, whole blood and brain were measured by a specific reverse phase HPLC-EC method described previously. 1 3 Intra-and inter-day variability for plasma and whole blood assays were less than 15%, and for whole brain less than 8% in the 0.25-10 g ml 91 and 1-25 g g 91 concentration ranges, respectively. Two-way ANOVA was used to test if arterial concentrations (plasma and whole blood) were significantly different at 3, 3.5 and 4 h. A two-tailed t test was used to test if Kp Brain:Plasma was different fromKp Brain:Blood (P:0.05).
Results
Arterial concentrations were not significantly different at 3-4 h or 3.5-4 h for plasma and whole blood, respectively, indicating that steady state had been achieved by 4 and Kp Brain:Blood (n:6) values (8.2 (SD 1.6) and 3.0 (0.5), respectively) were significantly different.
Discussion
For lipid soluble i.v. anaesthetics, the rate and extent of tissue distribution, and the rate of equilibration between blood and brain are important determinants of the rate of onset, intensity and duration of pharmacological effect. The half-life for effect-site equilibration and turnover is quantitatively summarized as the pharmacokinetic-pharmacodynamic link variable T 1/2 k E0 . The brain:plasma solubility (Kp Brain:Plasma ) of propofol is in agreement with its high lipophilicity. However, simultaneous occurrence of high Kp Brain:Plasma and rapid effect-site turnover are contrary to our current understanding of how volume-flow relationships determine tissue and effect-site turnover.
A drug must exhibit high lipid solubility to rapidly transfer across the blood-brain barrier. As most i.v. anaesthetics, benzodiazepines and opioids (excluding morphine) are highly lipid soluble (Kp Octanol-Water 92), membrane permeability or plasma binding does not appear to limit brain uptake. It is believed that for these drugs, the rate of brain uptake (and time to equilibrium with blood) is determined primarily by regional blood flow. Under these conditions the brain can be envisioned as a well stirred compartment with an apparent volume of distribution (V App ) equal to the product of brain weight (WT Brain ) and Kp Brain:Plasma :
V app =Kp Brain:Plasma WT Brain (1a) Alternatively, V App of brain can be calculated relative to whole blood concentrations:
Clearance (Cl Brain ) governing uptake and washout of drug from this well stirred compartment is brain plasma flow (Q Plasma ):
If drug bound to formed elements and plasma proteins is readily available for parenchymal distribution, then blood flow (Q Blood ) becomes operative clearance:
As with all well stirred systems, the half-time for drug turnover in the compartment should be predicted by the following volume-flow relationship (eqn (3a) or (3b)):
Half-time for brain turnover 
These principles have been reviewed by Ebling, Wada and Stanski. 4 Half-time for brain turnover has been found to be highly correlated to effect-site equilibration half-time (T 1/2 k E0 ) for thiopental 4 5 and propofol. 1 If we assume whole brain distribution kinetics to be indistinguishable from the hypothetical effect-site then for most anaesthetic agents the kinetic-dynamic variable T 1/2 k E0 should reflect tissue turnover and be described by: 1 2 Brain:Plasma Figure 1 illustrates the linear relationship between brain:plasma solubility and T 1/2 k E0 for lipid soluble benzodiazepines (diazepam 6 7 and midazolam 7 8 ), a barbiturate (thiopental 4 5 ) and opioids (methadone 9 10 , alfentanil 11 12 and fentanyl 11 12 ). Propofol, the most lipid soluble anaesthetic based on brain:plasma solubility, exists at the far right of the brain solubility-T 1/2 k E0 relationship. Basing brain solubility on whole blood concentrations places propofol T 1/2 k E0 at a locus more in agreement with the brain solubility-T 1/2 k E0 relationship for other anaesthetics. This finding suggests that all propofol molecules entering the vascular space of the brain, irrespective of whether they are bound to plasma proteins or formed elements of blood, can transfer into parenchyma. This also suggests that propofol is likely to be non-restrictively bound to the formed elements of blood and plasma proteins. (Non-restrictive binding implies that the capillary transit time through the organ must be several times greater than the halftime of dissociation from the formed elements of blood, allowing complete uptake of drug bound to arterial blood elements.)
The rationale for this conclusion is as follows. 
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Propofol is highly bound to plasma proteins (97% ) By assuming that drug bound to plasma proteins can completely dissociate during capillary transit and fully participate in transfer, similar calculations (eqn (4a)) yield a T 1/2 k E0 of approximately 8.3 min. Both scenarios are untenable as the calculations significantly over-predict the observed T 1/2 k E0 . If we assume that drug bound to plasma proteins and formed elements of blood can transfer into parenchyma, then equation (4b) predicts a T 1/2 k E0 value of 1.7 min. Therefore, it appears that whole blood and not plasma or free-water concentration is the thermodynamically relevant species for propofol brain uptake in rats.
Drug transfer across membranes is believed to be governed by the free-water diffusion hypothesis that assumes that free drug concentration is the thermodynamic driving force involved in all kinetic processes. If this hypothesis holds for propofol then this anaesthetic must be non-restrictively bound to plasma proteins and formed elements of blood to allow for complete dissociation during a single circulatory pass through the brain. Non-restrictive binding places an upper limit on the half-time for dissociation of approximately 400 ms. (Rat brain blood flow is 1.25 ml min 91 g 91 and brain blood volume is 3% of brain weight. 4 If the half-time for dissociation into plasma water from formed elements of blood and plasma proteins exceeds capillary transit time, then one must hypothesize that blood-brain transfer does not occur through free-water diffusion. Other transfer mechanisms such as the carrier-collision hypothesis 14 which suggests rapid membrane to membrane or protein to membrane transfer would have to be evoked to explain the observed phenomena. It is unknown if this phenomena occurs for propofol or other highly lipid soluble, low molecular weight compounds. Irrespective of the mechanism, propofol demonstrates extraordinary mobility across physiological boundaries.
